Livzon Group (Ningxia) Pharmaceutical Co., Ltd.December 6, 2019

FDA 483 - Livzon Group (Ningxia) Pharmaceutical Co., Ltd. - December 06, 2019

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Livzon Group (Ningxia) Pharmaceutical Co., Ltd.

Record Details

Lizvon Group (Ningxia) Pharmaceutical Co., an intermediate and API manufacturer, was cited for significant deficiencies during an FDA inspection. Observations included failures in maintaining manufacturing equipment, specifically rusted tanks, and a lack of thorough investigation into out-of-specification results for multiple batches. These findings indicate issues with equipment integrity and quality control processes.

Company: Livzon Group (Ningxia) Pharmaceutical Co., Ltd.
Inspection Date: December 6, 2019
Product Type: Drugs
Office: Office of Biological Products Operations - Division I
People: Vincent Thomas
Jose M. Cayuela

Open in Dashboard

ID · 9bfeb219-f90b-492a-9ffd-2097dfac7b48